Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 Signaling.
Saved in:
| Title: | Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 Signaling. |
|---|---|
| Authors: | Goldstein NB; Department of Dermatology, University of Colorado, Aurora, Colorado, USA., Steel A; Department of Dermatology, University of Colorado, Aurora, Colorado, USA., Barbulescu CC; Department of Dermatology, University of Colorado, Aurora, Colorado, USA., Koster MI; Department of Dermatology, University of Colorado, Aurora, Colorado, USA; Gates Center for Regenerative Medicine, University of Colorado, Aurora, Colorado, USA., Wright MJ; Department of Dermatology, University of Colorado, Aurora, Colorado, USA; Gates Center for Regenerative Medicine, University of Colorado, Aurora, Colorado, USA., Jones KL; Department of Hematology, University of Colorado, Aurora, Colorado, USA; Department of Pediatrics, University of Colorado, Aurora, Colorado, USA., Gao B; Sequencing and Microarray Core, University of Colorado, Aurora, Colorado, USA., Ward B; Department of Dermatology, University of Colorado, Aurora, Colorado, USA; Gates Center for Regenerative Medicine, University of Colorado, Aurora, Colorado, USA., Woessner B; Sequencing and Microarray Core, University of Colorado, Aurora, Colorado, USA., Trottier Z; Department of Dermatology, University of Colorado, Aurora, Colorado, USA; Gates Center for Regenerative Medicine, University of Colorado, Aurora, Colorado, USA., Pakieser J; Department of Dermatology, University of Colorado, Aurora, Colorado, USA; Gates Center for Regenerative Medicine, University of Colorado, Aurora, Colorado, USA., Hu J; Department of Pediatrics, University of Colorado, Aurora, Colorado, USA; Cancer Center Biostatistics Core, University of Colorado, Aurora, Colorado, USA., Lambert KA; Department of Dermatology, University of Colorado, Aurora, Colorado, USA., Shellman YG; Department of Dermatology, University of Colorado, Aurora, Colorado, USA., Fujita M; Department of Dermatology, University of Colorado, Aurora, Colorado, USA; Gates Center for Regenerative Medicine, University of Colorado, Aurora, Colorado, USA; Denver Department of Veterans Affairs Medical Center, Denver, Colorado, USA., Robinson WA; Division of Oncology, University of Colorado, Aurora, Colorado, USA., Roop DR; Department of Dermatology, University of Colorado, Aurora, Colorado, USA; Gates Center for Regenerative Medicine, University of Colorado, Aurora, Colorado, USA., Norris DA; Department of Dermatology, University of Colorado, Aurora, Colorado, USA; Gates Center for Regenerative Medicine, University of Colorado, Aurora, Colorado, USA; Denver Department of Veterans Affairs Medical Center, Denver, Colorado, USA., Birlea SA; Department of Dermatology, University of Colorado, Aurora, Colorado, USA; Gates Center for Regenerative Medicine, University of Colorado, Aurora, Colorado, USA; Human Medical Genetics and Genomics Program, Aurora, Colorado, USA. Electronic address: Stanca.Birlea@cuanschutz.edu. |
| Source: | The Journal of investigative dermatology [J Invest Dermatol] 2021 Mar; Vol. 141 (3), pp. 638-647.e13. Date of Electronic Publication: 2020 Aug 13. |
| Publication Type: | Journal Article; Observational Study; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
